Human Genome Epidemiology Literature Finder
Records 1 - 3 (of 3 Records) |
Query Trace: Sarcoma and EZH2[original query] |
---|
Genomic landscape of Ewing sarcoma defines an aggressive subtype with co-association of STAG2 and TP53 mutations. Cancer discovery 2014 Nov 4 (11): 1342-53. Tirode Franck, Surdez Didier, Ma Xiaotu, Parker Matthew, Le Deley Marie Cécile, Bahrami Armita, Zhang Zhaojie, Lapouble Eve, Grossetête-Lalami Sandrine, Rusch Michael, Reynaud Stéphanie, Rio-Frio Thomas, Hedlund Erin, Wu Gang, Chen Xiang, Pierron Gaelle, Oberlin Odile, Zaidi Sakina, Lemmon Gordon, Gupta Pankaj, Vadodaria Bhavin, Easton John, Gut Marta, Ding Li, Mardis Elaine R, Wilson Richard K, Shurtleff Sheila, Laurence Valérie, Michon Jean, Marec-Bérard Perrine, Gut Ivo, Downing James, Dyer Michael, Zhang Jinghui, Delattre Olivier, |
Low mutation burden and frequent loss of CDKN2A/B and SMARCA2, but not PRC2, define premalignant neurofibromatosis type 1-associated atypical neurofibromas. Neuro-oncology 2019 2 21 (8): 981-992. Pemov Alexander, Hansen Nancy F, Sindiri Sivasish, Patidar Rajesh, Higham Christine S, Dombi Eva, Miettinen Markku M, Fetsch Patricia, Brems Hilde, Chandrasekharappa Settara C, Jones Kristine, Zhu Bin, Wei Jun S, , , Mullikin James C, Wallace Margaret R, Khan Javed, Legius Eric, Widemann Brigitte C, Stewart Douglas |
Polycomb repressive complex 2 mutations predict survival benefit in advanced cancer patients treated with immune checkpoint inhibitors. Immuno-oncology technology 2022 6 10 100035. Vlachostergios P |
- Page last reviewed:Feb 1, 2023
- Page last updated:May 22, 2023
- Content source: